JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 8, 2005; DOI: 10.1124/jpet.105.096958


0022-3565/06/3171-19-29$20.00
JPET 317:19-29, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.096958v1
317/1/19    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, H.-L.
Right arrow Articles by Pelligrino, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, H.-L.
Right arrow Articles by Pelligrino, D. A.

INFLAMMATION AND IMMUNOPHARMACOLOGY

Vascular Adhesion Protein-1 Plays an Important Role in Postischemic Inflammation and Neuropathology in Diabetic, Estrogen-Treated Ovariectomized Female Rats Subjected to Transient Forebrain Ischemia

Hao-Liang Xu, Luisa Salter-Cid, Matthew D. Linnik, Eric Y. Wang, Chanannait Paisansathan, and Dale A. Pelligrino

Neuroanesthesia Research Laboratory, University of Illinois at Chicago, Chicago, Illinois (H.-L.X., C.P., D.A.P.); and La Jolla Pharmaceutical Company, San Diego, California (L.S.-C., M.D.L., E.Y.W.)

Endothelial vascular adhesion protein-1 (VAP-1) facilitates leukocyte adhesion and infiltration. This relates partly to the function of VAP-1 as a semicarbazide-sensitive amine oxidase (SSAO). We examined the effects of VAP-1/SSAO inhibition [via LJP-1207 (N'-(2-phenyl-allyl)-hydrazine hydrochloride)] on pial venular leukocyte adhesion and infiltration (at 2–10 h of reperfusion) and neuropathology (at 72 h of reperfusion) after transient forebrain ischemia (TFI). A model associated with increased postischemic inflammation was used—i.e., diabetic ovariectomized (OVX) female rats given chronic estrogen replacement therapy (ERT). We compared rats treated, either at the onset or at 6 h of reperfusion, with saline or LJP-1207. Additional rats, rendered neutropenic 24 h before TFI, were studied. In saline-treated controls, intravascular accumulation of adherent leukocytes gradually increased, reaching 15 to 20% of the venular area, at which point neutrophil infiltration commenced (at ~6 h). In the rats given LJP-1207 at the onset of reperfusion, limited neutrophil adhesion (~5% maximum) and no infiltration were observed. These results generally paralleled those in neutropenic rats. In rats treated at 6 h of reperfusion, the pattern of neutrophil adhesion was similar to that of the saline-treated group up to 6 h, but further infiltration was essentially prevented. Neurologic outcomes and histopathology were similar to one another in the LJP-1207-treated and neutropenic groups and significantly improved over those in saline-treated controls. Thus, VAP-1-mediated post-TFI leukocyte adhesion/infiltration in diabetic OVX females given chronic ERT contributes substantially to neuropathology. One implication is that specifically preventing leukocyte infiltration provides a substantial measure of neuroprotection. This could explain the finding of LJP-1207 having at least a 6-h therapeutic window in this model.


Received October 12, 2005; accepted December 6, 2005.

Address correspondence to: Dr. Dale A. Pelligrino, Professor and Director, Neuroanesthesia Research Laboratory, University of Illinois at Chicago, Molecular Biology Research Building, Room 4320, 900 S. Ashland Avenue, Chicago, IL 60607. E-mail: dpell{at}uic.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. M. O'Rourke, E. Y. Wang, A. Miller, E. M. Podar, K. Scheyhing, L. Huang, C. Kessler, H. Gao, H.-T. Ton-Nu, M. T. MacDonald, et al.
Anti-Inflammatory Effects of LJP 1586 [Z-3-Fluoro-2-(4-methoxybenzyl)allylamine Hydrochloride], an Amine-Based Inhibitor of Semicarbazide-Sensitive Amine Oxidase Activity
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 867 - 875.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Jalkanen and M. Salmi
VAP-1 and CD73, Endothelial Cell Surface Enzymes in Leukocyte Extravasation
Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 18 - 26.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. N. Krause, S. P. Duckles, and D. A. Pelligrino
Influence of sex steroid hormones on cerebrovascular function
J Appl Physiol, October 1, 2006; 101(4): 1252 - 1261.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.